Legacy MD Medical Group in El Centro, CA, has recently acquired cutting-edge Fibroscan technology for liver elastography, a non-invasive diagnostic tool that assesses liver health by measuring liver stiffness and fat content. This advanced equipment allows healthcare providers at Legacy MD to better evaluate liver conditions such as fibrosis and steatosis, enabling more effective monitoring and management of liver diseases. The Fibroscan provides quick, reliable data, empowering physicians to initiate timely interventions and personalized treatment plans for patients.
Victor Murguia, Executive Manager at Legacy MD, expressed excitement about the introduction of Fibroscan technology, highlighting its ability to enhance the practice’s capabilities in liver assessments. This state-of-the-art equipment replaces more invasive methods like liver biopsy, reducing patient discomfort and recovery time significantly.
Liver diseases are prevalent, with over 100 million people in the U.S. affected. If left untreated, liver disease can lead to severe conditions like liver failure and liver cancer. Legacy MD’s adoption of Fibroscan technology represents a significant step towards improving patient care and outcomes in the region.
For more information about Fibroscan and its availability at Legacy MD – VO Medical Center, individuals can contact the practice at (760) 352-2551 or visit www.vomedicalcenter.com. The implementation of Fibroscan technology underscores Legacy MD’s commitment to providing comprehensive and innovative care to its patients.
Source
Photo credit holtvilletribune.com